27 MAGGIO 2020: CONSIDERAZIONI SULL’USO DELL’IDROSSICLOROCHINA NEI PAZIENTI CON DIABETE MELLITO
Leggi l’articolo qui
HEALIO NEWS (JUNE 3, 2020): “LONG-TERM DATA LACKING FOR HYDROXYCHLOROQUINE USE IN TYPE 2 DIABETES, COVID-19”
Leggi l’articolo qui
“TYPE 1 DIABETES AND TECHNOLOGICAL ADVANCES: TOWARDS THE ARTIFICIAL PANCREAS”
Interview for “Sanità & Benessere” (February 2021) – “Type 1 diabetes and technological advances: towards the artificial pancreas” Read the article here
“DIABETE DI TIPO 1 E INNOVAZIONI TECNOLOGICHE: VERSO IL PANCREAS ARTIFICIALE”
Intervista per “Sanità & Benessere” (Febbraio 2021) – “Diabete di tipo 1 e innovazioni tecnologiche: verso il pancreas artificiale” Leggi l’articolo qui
ARTICOLO DEL DR. INFANTE PUBBLICATO SUL “THE EUROPE AND FOOD REPORT” DEL BARILLA CENTER FOR FOOD & NUTRITION (BCFN) 2021 – “TOWARDS A SUSTAINABLE PREVENTION OF TYPE 2 DIABETES”
Leggi l’articolo qui
L’ARTICOLO DEL DR. INFANTE “ANTIHYPERGLYCEMIC PROPERTIES OF HYDROXYCHLOROQUINE IN PATIENTS WITH DIABETES: RISKS AND BENEFITS AT THE TIME OF COVID-19 PANDEMIC” INCLUSO TRA I TOP CITED ARTICLES DI JOURNAL OF DIABETES PER IL PERIODO 2020-2021
L’ARTICOLO DEL DR. INFANTE “ANTIHYPERGLYCEMIC PROPERTIES OF HYDROXYCHLOROQUINE IN PATIENTS WITH DIABETES: RISKS AND BENEFITS AT THE TIME OF COVID-19 PANDEMIC” INCLUSO TRA I TOP CITED ARTICLES DI JOURNAL OF DIABETES PER IL PERIODO 2020-2021 Infante M, Ricordi C, Fabbri A. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time […]
LA RIVISTA SCIENTIFICA ARTIFICIAL ORGANS (WILEY) DEDICA LA COVER DELL’ISSUE DI SETTEMBRE 2021 ALL’ARTICOLO DEL DR. INFANTE INTITOLATO “DUAL-HORMONE ARTIFICIAL PANCREAS FOR MANAGEMENT OF TYPE 1 DIABETES: RECENT PROGRESS AND FUTURE DIRECTIONS”
“Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions” by Marco Infante, David A. Baidal, Michael R. Rickels, Andrea Fabbri, Jay S. Skyler, Rodolfo Alejandro and Camillo Ricordi. Artif Organs. 2021 Sep;45(9):968-986. DOI: 10.1111/aor.14023. Leggi l’articolo qui
“Criteri per lo screening “cost-effective” della carenza di vitamina B12 nei pazienti trattati con metformina (proposti e pubblicati dal Dr. Marco Infante su World Journal of Diabetes, 2021 Jul 15;12(7):916-931)”
Leggi l’articolo qui
LA RIVISTA SCIENTIFICA “MEDICINA” (MDPI) DEDICA LA COVER DELL’ISSUE DI MAGGIO 2022 ALL’ARTICOLO DEL DR. INFANTE “DIABETES-MODIFYING ANTIRHEUMATIC DRUGS: THE ROLES OF DMARDs AS GLUCOSE-LOWERING AGENTS”
Read the article here
“AN UNUSUAL CASE OF AUTOANTIBODY-NEGATIVE KETOSIS-PRONE DIABETES (KPD) SECONDARY TO MARKED INSULIN RESISTANCE”: POSTER PRESENTATO DAL DR. INFANTE ALL’AMERICAN DIABETES ASSOCIATION (ADA) MEETING 2022 (ADA’s 82nd SCIENTIFIC SESSIONS, 3-7 GIUGNO 2022, NEW ORLEANS, LOUISIANA, LA, USA)
Read the article here